
HISUN USA
Bridgewater, NJ, China · hisunusa.com
GMP
HISUN USA develops and commercializes pharmaceutical and biotechnology products and provides contract manufacturing services for API, drug products, and biologics. It serves human and veterinary pharmaceutical markets from Bridgewater, New Jersey, with headquarters and manufacturing and development locations in China.
They take quote requests by email.
What they offer
API Service & Nutritional Products
Provides custom services for nutritional products, complex advanced intermediates, and custom APIs, including support from early research through clinical development and commercial supply.
Drug Product Service
Provides finished dosage services for oral, injectable, and special delivery drug products, including solid dosage, aseptic fill-finish, lyophilization, and packaging.
Biological Service
Provides custom biologics manufacturing services and co-development for biosimilars, including monoclonal antibodies, recombinant proteins, peptides, cell factors, vaccines, and antibody-drug conjugates.
R&D
Develops and commercializes novel pharmaceutical and biotechnology products for the US, China, and other global markets.
Contract Manufacturing
Operates a globally integrated network of manufacturing facilities to manufacture and deliver finished products.
What they work on
- Modalities
- Small molecule, Antibody, ADC, Peptide, Recombinant protein, Vaccine, Biosimilar
- Species and models
- bacteria, filamentous fungi, mammalian, cell culture lines
- Assays and studies
- custom services, protein engineering, cell line development, cloning, protein expression, downstream processing
- Instruments and platforms
- industrial scale column chromatography, evaporators-short path, thin film
- Scale and capacity
- 4 manufacturing facilities, more than 10 workshops, 50 chemical synthesis production lines, over 680 reactors from 20L to 8,000L, over 240 fermenters from 1 to 80m 3, more than 8,000m 3 of fermentation capacity, pilot plant tablets: 3M/year, production plant tablets: 7B/year, capsules: 2B/year, injectable capacity: 0.25-15 Million vials/year, 1-100 mL volume/vial, microbial lines 500L, 2x15,00L
- Therapeutic areas
- oncology, anti-Infective, cardiovascular, neurological diseases
- Type
- CRDMO
- Sites
- Bridgewater, NJ, USA · Taizhou City, China · Beijing, China · Shanghai, China · Fuyang, China · Nantong, China
- Serves
- US, China, additional global markets, more than 60 countries
- Address
- 200 Crossing Blvd, 2nd Floor Bridgewater, NJ 08807
- Founded
- 2003
Similar labs. Aurigene Pharmaceutical Services, Biofidus GmbH, Sparx BIO, 3C Therapeutics
Found in a contract services directory. Listing built from hisunusa.com. Work here? Claim this listing.